Skip to content
Search

Latest Stories

GPhC appoints Gisela Abbam as its new chair

General Pharmaceutical Council (GPhC) has appointed Gisela Abbam as its new chair.

Appointment of Abbam, who will assume office on March 14, 2022, was made by the Privy Council after a robust selection process which was scrutinised by the Professional Standards Authority.


She will take over from the current chair, Nigel Clarke, who has been in position since 2014 and has completed the statutory maximum eight years in office.

Commenting on her appointment, Abbam said: "I am delighted and honoured to be appointed as the new chair of the General Pharmaceutical Council and I look forward to leading the Council to achieve its vision of safe and effective pharmacy care at the heart of healthier communities.

“Covid-19 highlighted the increased role of pharmacists, pharmacy technicians and pharmacies in providing clinical services. Effective standards and regulation can help pharmacy to provide more support to patients and the public at large. I look forward to working with Council, the Executive team and staff and collaborating with other organisations to improve the health of people using pharmacy services."

Welcoming Abbam to the Council, Clarke, said: “Gisela is joining the GPhC at an exciting time of major changes in both pharmacy and health regulation. I am sure her vast experience in healthcare will help the GPhC drive forward the aims set out in our Vision 2030, and bring a real focus on the difference we want to make for patients and the public.”

Previously, Abbam was chair of the British Science Association (BSA). During her tenure, she led the BSA’s Council and championed the BSA mission and vision, driving forward an agenda on equality, diversity, and inclusion in STEM (Science, Technology, Engineering and Maths).

She has worked in collaboration with governments, the World Health Organisation, the United Nations, and other multilateral organisations to improve health outcomes for people across the world.

She is also the senior director government affairs for EMEAI at PerkinElmer, a global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalised drugs, monitor the safety and quality of food.

Besides, she serves on a number of advisory committees and sits on the Board of Everywoman Ltd., an organisation dedicated to advancing women in business.

Many in the industry congratulated the Council on the new appointment.

Welcoming the new GPhC chair, Mark Lyonette, chief executive of National Pharmacy Association wrote on twitter, “looking forward to meeting @gmabbam once she starts.

Mark tweet

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less
NPA urges immediate release of pharmacy funding crises review
Underfunding has forced record numbers of pharmacy closures (gettyimages)

Suppressing pharmacy funding crisis analysis would be ‘outrageous’, warns NPA

The NPA fears the report won’t be published until pharmacy funding consultations conclude, while CPE states there is no set timeline for finalising negotiations.

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis.

Commissioned by NHS England, the long-awaited independent review is expected to “lay bare the perilous financial state” of community pharmacies, which is a vital part of the nation’s health infrastructure.

Keep ReadingShow less